The psychedelics industry is years away and billions of dollars short of its promise of transforming medical care
businessinsider.com
news
2022-06-05 12:47:00

In just a few short years, the psychedelics industry has become crowded with ambitious companies racing to develop medicines for conditions like depression and PTSD.Their goal is to transform compounds like MDMA and psilocybin into new medical treatments that can be prescribed to millions of people with health conditions for which there are few good options right now.The business opportunity is immense. Analysts at H.C. Wainwright estimate that peak sales at nine leading psychedelics companies could eventually reach a total of $35 billion, though that peak is more than a decade away.
